
Emkay has claimed that a mid-cap Pharma stock, which is already certified as a potential “100-bagger”, has made a “giant leap” and deserves to be accumulated
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments